Alzheimer’s disease (1987-2012)

According to population ageing, Alzheimer Disease is major health concern and the Fondation IPSEN decided in 1980 to inform the scientific and medical communities of the recent advances.

Colloques Médecine et Recherche 

Years ago, when the disease was still almost unknown, Fondation IPSEN was already deeply committed to helping the scientific and medical community to understand its importance. This commitment has not stopped at encouraging the circulation of knowledge: Fondation IPSEN has also strived to ensure that research into Alzheimer’s disease and related neurodegenerative conditions benefits from all the progress of modern cellular and molecular biology.

The Fondation IPSEN’s Colloques Médecine et Recherche on Alzheimer’s disease have often been the first to deal with the latest discoveries in the field.


  • Proteopatics seeds and neurodegenerative diseases
    Paris (France), February 27, 2012
  • Protein quality control in neurodegenerative diseases
    Paris (France), May 9, 2011
  • Two faces of evil: cancer and neurodegeneration
    Paris (France), April 26, 2010
  • Diabetes, insulin and Alzheimer’s disease
    Paris (France), April 6, 2009
  • Intracellular traffic and neurodegenerative disorders
    Paris (France), April 28, 2008
  • Synaptic plasticity and the mechanism of Alzheimer’s disease
    Paris (France), April 7, 2007
  • Alzheimer: 100 years and beyond (in collaboration with Tübingen University)
    Tübingen (Germany), November 2-5, 2006
  • Genotype – proteotype – phenotype relationships in neurodegenerative diseases
    Paris (France), September 13, 2004
  • The living brain and Alzheimer’s disease
    Paris (France), March 17, 2003
  • Immunization against Alzheimer’s and other neurodegenerative diseases
    Paris (France), March 13, 2002
  • Notch from neurodevelopment to neurodegeneration: keeping the fate
    Paris, March 19, 2001
  • Neurodegenerative diseases: loss of function through gain of function
    Paris (France), February 28, 2000
  • Fatal Attractions within Neurons: intracytoplasmic protein aggregates in Alzheimer’s disease and related Neurodegenerative Disorders
    Paris (France), April 12,1999
  • Epidemiology of Alzheimer’s disease: from gene to prevention
    Paris (France), May 11, 1998
  • Presenilins and Alzheimer’s disease
    Paris (France), April 28, 1997
  • Connections, cognition and Alzheimer’s disease
    Paris (France), May 20, 1996
  • Apolipoprotein E and Alzheimer’s disease
    Paris (France), May 29, 1995
  • Alzheimer’s disease: lessons from cell biology
    Paris (France), April 25, 1994
  • The ß-Amyloid protein precursors in development, aging and Alzheimer’s disease
    Lyon (France), June 21, 1993
  • Heterogeneity of Alzheimer’s disease
    Marseille (France), April 6, 1992
  • Neurophilosophy and Alzheimer’s disease
    San Diego (USA), January 11, 1991
  • Growth factors and Alzheimer’s disease
    Strasbourg (France), April 25, 1990
  • Imaging, cerebral topography and Alzheimer’s disease
    Lille (France), October 16, 1989
  • Biological markers of Alzheimer’s disease
    Toulouse (France), April 24, 1989
  • Neuronal grafting and Alzheimer’s disease: future perspectives
    Montpellier (France), September 19, 1988
  • Genetics and Alzheimer’s disease
    Paris (France), March 25, 1988
  • Immunological aspects of Alzheimer’s disease and brain amyloidosis
    Angers (France), September 18, 1987